A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR.

Neoplasia · 2025 · PMC11609319 · PMID 39541736

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A trend in decreased p-mTOR(Ser 2248 ) did not reach statistical significance and phosphorylation of p-JNK(Thr 183 /Tyr 185 ), but p-PTEN(Ser 380 ) remained unchanged.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.